<DOC>
	<DOCNO>NCT00705172</DOCNO>
	<brief_summary>This study conduct Europe . The aim observational study collect data child Prader-Willi Syndrome , treat off-label Norditropin® 12 month seek approval Norditropin® treatment Prader-Willi Syndrome .</brief_summary>
	<brief_title>Retrospective Observational Study Efficacy Safety Norditropin® Children With Prader-Willi Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Prader-Willi Syndrome</mesh_term>
	<criteria>Informed consent obtain trialrelated activity Genetically diagnose PraderWilli Syndrome Received least one dose Norditropin® treatment Prepubertal start treatment ; assess Tanner stage 1 , testicular volume 4ml ( accord Tanner 1976 ) Pretreatment Growth Hormone preparation prior treatment Norditropin®</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>